-
Per-event Uncertainty Quantification for Flow Cytometry using Calibration Beads
Authors:
Prajakta Bedekar,
Megan A. Catterton,
Matthew DiSalvo,
Gregory A. Cooksey,
Anthony J. Kearsley,
Paul N. Patrone
Abstract:
Flow cytometry measurements are widely used in diagnostics and medical decision making. Incomplete understanding of sources of measurement uncertainty can make it difficult to distinguish autofluorescence and background sources from signals of interest. Moreover, established methods for modeling uncertainty overlook the fact that the apparent distribution of measurements is a convolution of the in…
▽ More
Flow cytometry measurements are widely used in diagnostics and medical decision making. Incomplete understanding of sources of measurement uncertainty can make it difficult to distinguish autofluorescence and background sources from signals of interest. Moreover, established methods for modeling uncertainty overlook the fact that the apparent distribution of measurements is a convolution of the inherent the population variability (e.g., associated with calibration beads or cells) and instrument induced-effects. Such issues make it difficult, for example, to identify signals from small objects such as extracellular vesicles. To overcome such limitations, we formulate an explicit probabilistic measurement model that accounts for volume and labeling variation, background signals and fluorescence shot noise. Using raw data from routine per-event calibration measurements, we use this model to separate the aforementioned sources of uncertainty and demonstrate how such information can be used to facilitate decision-making and instrument characterization.
△ Less
Submitted 28 November, 2024;
originally announced November 2024.
-
Uncertainty Quantification of Antibody Measurements: Physical Principles and Implications for Standardization
Authors:
Paul N. Patrone,
Lili Wang,
Sheng Lin-Gibson,
Anthony J. Kearsley
Abstract:
Harmonizing serology measurements is critical for identifying reference materials that permit standardization and comparison of results across different diagnostic platforms. However, the theoretical foundations of such tasks have yet to be fully explored in the context of antibody thermodynamics and uncertainty quantification (UQ). This has restricted the usefulness of standards currently deploye…
▽ More
Harmonizing serology measurements is critical for identifying reference materials that permit standardization and comparison of results across different diagnostic platforms. However, the theoretical foundations of such tasks have yet to be fully explored in the context of antibody thermodynamics and uncertainty quantification (UQ). This has restricted the usefulness of standards currently deployed and limited the scope of materials considered as viable reference material. To address these problems, we develop rigorous theories of antibody normalization and harmonization, as well as formulate a probabilistic framework for defining correlates of protection. We begin by proposing a mathematical definition of harmonization equipped with structure needed to quantify uncertainty associated with the choice of standard, assay, etc. We then show how a thermodynamic description of serology measurements (i) relates this structure to the Gibbs free-energy of antibody binding, and thereby (ii) induces a regression analysis that directly harmonizes measurements. We supplement this with a novel, optimization-based normalization (not harmonization!) method that checks for consistency between reference and sample dilution curves. Last, we relate these analyses to uncertainty propagation techniques to estimate correlates of protection. A key result of these analyses is that under physically reasonable conditions, the choice of reference material does not increase uncertainty associated with harmonization or correlates of protection. We provide examples and validate main ideas in the context of an interlab study that lays the foundation for using monoclonal antibodies as a reference for SARS-CoV-2 serology measurements.
△ Less
Submitted 30 August, 2024;
originally announced September 2024.
-
Optimal classification and generalized prevalence estimates for diagnostic settings with more than two classes
Authors:
Rayanne A. Luke,
Anthony J. Kearsley,
Paul N. Patrone
Abstract:
An accurate multiclass classification strategy is crucial to interpreting antibody tests. However, traditional methods based on confidence intervals or receiver operating characteristics lack clear extensions to settings with more than two classes. We address this problem by developing a multiclass classification based on probabilistic modeling and optimal decision theory that minimizes the convex…
▽ More
An accurate multiclass classification strategy is crucial to interpreting antibody tests. However, traditional methods based on confidence intervals or receiver operating characteristics lack clear extensions to settings with more than two classes. We address this problem by developing a multiclass classification based on probabilistic modeling and optimal decision theory that minimizes the convex combination of false classification rates. The classification process is challenging when the relative fraction of the population in each class, or generalized prevalence, is unknown. Thus, we also develop a method for estimating the generalized prevalence of test data that is independent of classification. We validate our approach on serological data with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) naïve, previously infected, and vaccinated classes. Synthetic data are used to demonstrate that (i) prevalence estimates are unbiased and converge to true values and (ii) our procedure applies to arbitrary measurement dimensions. In contrast to the binary problem, the multiclass setting offers wide-reaching utility as the most general framework and provides new insight into prevalence estimation best practices.
△ Less
Submitted 5 October, 2022;
originally announced October 2022.
-
Prevalence Estimation and Optimal Classification Methods to Account for Time Dependence in Antibody Levels
Authors:
Prajakta Bedekar,
Anthony J. Kearsley,
Paul N. Patrone
Abstract:
Serology testing can identify past infection by quantifying the immune response of an infected individual providing important public health guidance. Individual immune responses are time-dependent, which is reflected in antibody measurements. Moreover, the probability of obtaining a particular measurement changes due to prevalence as the disease progresses. Taking into account these personal and p…
▽ More
Serology testing can identify past infection by quantifying the immune response of an infected individual providing important public health guidance. Individual immune responses are time-dependent, which is reflected in antibody measurements. Moreover, the probability of obtaining a particular measurement changes due to prevalence as the disease progresses. Taking into account these personal and population-level effects, we develop a mathematical model that suggests a natural adaptive scheme for estimating prevalence as a function of time. We then combine the estimated prevalence with optimal decision theory to develop a time-dependent probabilistic classification scheme that minimizes error. We validate this analysis by using a combination of real-world and synthetic SARS-CoV-2 data and discuss the type of longitudinal studies needed to execute this scheme in real-world settings.
△ Less
Submitted 3 August, 2022;
originally announced August 2022.
-
Modeling in higher dimensions to improve diagnostic testing accuracy: theory and examples for multiplex saliva-based SARS-CoV-2 antibody assays
Authors:
Rayanne A. Luke,
Anthony J. Kearsley,
Nora Pisanic,
Yukari C. Manabe,
David L. Thomas,
Christopher D. Heaney,
Paul N. Patrone
Abstract:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the importance and challenges of correctly interpreting antibody test results. Identification of positive and negative samples requires a classification strategy with low error rates, which is hard to achieve when the corresponding measurement values overlap. Additional uncertainty arises when classification s…
▽ More
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has emphasized the importance and challenges of correctly interpreting antibody test results. Identification of positive and negative samples requires a classification strategy with low error rates, which is hard to achieve when the corresponding measurement values overlap. Additional uncertainty arises when classification schemes fail to account for complicated structure in data. We address these problems through a mathematical framework that combines high dimensional data modeling and optimal decision theory. Specifically, we show that appropriately increasing the dimension of data better separates positive and negative populations and reveals nuanced structure that can be described in terms of mathematical models. We combine these models with optimal decision theory to yield a classification scheme that better separates positive and negative samples relative to traditional methods such as confidence intervals (CIs) and receiver operating characteristics. We validate the usefulness of this approach in the context of a multiplex salivary SARS-CoV-2 immunoglobulin G assay dataset. This example illustrates how our analysis: (i) improves the assay accuracy (e.g. lowers classification errors by up to 42 % compared to CI methods); (ii) reduces the number of indeterminate samples when an inconclusive class is permissible (e.g. by 40 % compared to the original analysis of the example multiplex dataset); and (iii) decreases the number of antigens needed to classify samples. Our work showcases the power of mathematical modeling in diagnostic classification and highlights a method that can be adopted broadly in public health and clinical settings.
△ Less
Submitted 9 November, 2022; v1 submitted 28 June, 2022;
originally announced June 2022.
-
Optimal Decision Theory for Diagnostic Testing: Minimizing Indeterminate Classes with Applications to Saliva-Based SARS-CoV-2 Antibody Assays
Authors:
Paul N. Patrone,
Prajakta Bedekar,
Nora Pisanic,
Yukari C. Manabe,
David L. Thomas,
Christopher D. Heaney,
Anthony J. Kearsley
Abstract:
In diagnostic testing, establishing an indeterminate class is an effective way to identify samples that cannot be accurately classified. However, such approaches also make testing less efficient and must be balanced against overall assay performance. We address this problem by reformulating data classification in terms of a constrained optimization problem that (i) minimizes the probability of lab…
▽ More
In diagnostic testing, establishing an indeterminate class is an effective way to identify samples that cannot be accurately classified. However, such approaches also make testing less efficient and must be balanced against overall assay performance. We address this problem by reformulating data classification in terms of a constrained optimization problem that (i) minimizes the probability of labeling samples as indeterminate while (ii) ensuring that the remaining ones are classified with an average target accuracy X. We show that the solution to this problem is expressed in terms of a bathtub principle that holds out those samples with the lowest local accuracy up to an X-dependent threshold. To illustrate the usefulness of this analysis, we apply it to a multiplex, saliva-based SARS-CoV-2 antibody assay and demonstrate up to a 30 % reduction in the number of indeterminate samples relative to more traditional approaches.
△ Less
Submitted 31 January, 2022;
originally announced February 2022.
-
Improving Baseline Subtraction for Increased Sensitivity of Quantitative PCR Measurements
Authors:
Paul N. Patrone,
Anthony J. Kearsley,
Erica L. Romsos,
Peter M. Vallone
Abstract:
Motivated by the current COVID-19 health-crisis, we examine the task of baseline subtraction for quantitative polymerase chain-reaction (qPCR) measurements. In particular, we present an algorithm that leverages information obtained from non-template and/or DNA extraction-control experiments to remove systematic bias from amplification curves. We recast this problem in terms of mathematical optimiz…
▽ More
Motivated by the current COVID-19 health-crisis, we examine the task of baseline subtraction for quantitative polymerase chain-reaction (qPCR) measurements. In particular, we present an algorithm that leverages information obtained from non-template and/or DNA extraction-control experiments to remove systematic bias from amplification curves. We recast this problem in terms of mathematical optimization, i.e. by finding the amount of control signal that, when subtracted from an amplification curve, minimizes background noise. We demonstrate that this approach can yield a decade improvement in sensitivity relative to standard approaches, especially for data exhibiting late-cycle amplification. Critically, this increased sensitivity and accuracy promises more effective screening of viral DNA and a reduction in the rate of false-negatives in diagnostic settings.
△ Less
Submitted 11 April, 2020;
originally announced April 2020.
